e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation
Sheila Zanoria (Farmington, United States of America), Sheila Zanoria, Richard ZuWallack, Bibek Singh Pannu
Source:
International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Session:
Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Session type:
Poster Discussion
Number:
3015
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sheila Zanoria (Farmington, United States of America), Sheila Zanoria, Richard ZuWallack, Bibek Singh Pannu. Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation. Eur Respir J 2015; 46: Suppl. 59, 3015
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Static lung volumes and spirometry measurements
Related content which might interest you:
Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Frequency of COPD exacerbations and severity of COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
A pilot study of CPAP therapy for excessive dynamic airway collapse during acute exacerbation of COPD
Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Year: 2014
Impact of frequent exacerbations in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
The clinical significance and frequency of bronchiectasis in COPD patients
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Spirometry quality in patients with COPD exacerbation, related to the “frequent exacerbator” phenotype
Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function
Year: 2013
Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Mukoregulatory drugs in treating COPD
Source: International Congress 2014 – Predictors
Year: 2014
Physical status and dependence levels in patients with COPD exacerbation
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014
COPD on anti-GERD therapy remains at higher risk for severe exacerbation
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT
Source: International Congress 2014 – Markers
Year: 2014
Assessing COPD profiles and outcomes by dyspnoea severity
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
COPD: Influence of patients’ nutritive status on the exacerbations rate
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Factors associated with cognitive dysfunction in COPD patients hospitalised with exacerbations
Source: International Congress 2014 – COPD markers
Year: 2014
Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Recording and response to hyperglycaemia in patients presenting with infective exacerbations of COPD
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept